Form 8-K - Current report:
SEC Accession No. 0001104659-25-003801
Filing Date
2025-01-15
Accepted
2025-01-15 17:00:21
Documents
13
Period of Report
2025-01-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253348d1_8k.htm   iXBRL 8-K 25680
  Complete submission text file 0001104659-25-003801.txt   201287

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250108.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250108_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250108_pre.xml EX-101.PRE 22375
15 EXTRACTED XBRL INSTANCE DOCUMENT tm253348d1_8k_htm.xml XML 3809
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 25533546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)